Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

clinical trial

Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00001452

P17countryUnited States of AmericaQ30
P921main subjecturethral benign neoplasmQ18557544
P4135maximum age70
P1050medical conditionsyndromeQ179630
adenomaQ272741
Carney complexQ1044007
Peutz-Jeghers syndromeQ1544989
P2899minimum age3
P1132number of participants100000
P6153research siteNational Institutes of HealthQ390551
P859sponsorEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentQ5409765
P580start time1995-01-24
P8363study typeobservational studyQ818574
P1476titleDefinition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions

Search more.